JF
APGE

Jump Financial’s Apogee Therapeutics APGE Stock Holding History

Jump Financial’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
+2,343
New +$211K ﹤0.01% 1663
2025
Q1 		– Sell
-20,867
Closed -$945K – 1570
2024
Q4 		$945K Buy
+20,867
New +$1.06M 0.02% 778
2024
Q3 		– Sell
-43,458
Closed -$1.71M – 1621
2024
Q2 		$1.71M Buy
+43,458
New +$2.11M 0.03% 614
2024
Q1 		– Sell
-18,344
Closed -$513K – 1877
2023
Q4 		$513K Buy
+18,344
New +$368K 0.02% 1052

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Jump Financial's APGE Position: Q2 2026 in Review

Jump Financial opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 2,343 shares worth $311K. The stake represents ﹤0.01% of the portfolio and ranks #1663 among its holdings. This is a return to the name: Jump Financial previously reported a position in APGE as recently as Q4 2024.

Jump Financial first reported a position in APGE in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.71M in Q2 2024. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Jump Financial held 2,343 shares of Apogee Therapeutics worth $311K as of Q2 2026.
  • Apogee Therapeutics was a new Jump Financial position in Q2 2026.
  • Apogee Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1663 holding.
  • Jump Financial first reported a position in Apogee Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Jump Financial's Apogee Therapeutics position peaked at $1.71M in Q2 2024.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.